NAMS Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

NewAmsterdam Pharma Company NV (NAMS.O) Moving Averages Convergence Divergence (MACD) indicator is -0.912, suggesting NAMS.O is Sell.

NewAmsterdam Pharma Company NV (NAMS.O) 20-Day simple moving average is 33.109, while NewAmsterdam Pharma Company NV (NAMS.O) share price is $31.12, making it Sell.

NewAmsterdam Pharma Company NV (NAMS.O) 60-Day simple moving average is 35.696, while NewAmsterdam Pharma Company NV (NAMS.O) share price is $31.12, making it Sell.

Technical Analysis for NAMS

Technical Sentiment Analysis for NewAmsterdam Pharma Company NV (NAMS) As of 2026-01-30, NewAmsterdam Pharma Company NV (NAMS) is exhibiting a Sell technical sentiment. Our proprietary analysis, which aggregates 11 technical signals, shows that 4 indicators are flashing buy, while 7 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for NAMS stands at 37.943, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at -0.912, providing a Sell signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 20.938 and the Commodity Channel Index (CCI) at -110.379 further confirm a -0.71 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, NAMS is trading above its 60-day moving average of $35.696 and above its 200-day long-term moving average of $27.463. Key price levels to watch include the immediate resistance at $34.948 and strong support at $30.168. A break above $34.948 could signal a bull continuation, while falling below $30.168 may test the next Fibonacci floor at $27.779.

NewAmsterdam Pharma Company NV (NAMS) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	25.388	27.779	30.168	32.559	34.948	37.339	39.728
Fibonacci	27.779	29.605	30.733	32.559	34.385	35.513	37.339

NewAmsterdam Pharma Company NV (NAMS) Technical Indicators

2026-01-30

Name	Value
RSI_14	37.943
STOCHk_14_3_3	20.938
STOCHd_14_3_3	25.887
CCI_20	-110.379
AO_5_34	-1.938
MOM_10	-0.71
MACD_12_26_9	-0.912

NewAmsterdam Pharma Company NV (NAMS) Relative Strength Index (RSI) is 37.943, creating a Neutral signal.

NewAmsterdam Pharma Company NV (NAMS) Stochastic Oscillator is 20.938, creating a Neutral signal.

NewAmsterdam Pharma Company NV (NAMS) Stochastic RSI is 25.887, creating a Neutral signal.

NewAmsterdam Pharma Company NV (NAMS) Commodity Channel Index (CCI) is -110.379, creating a Buy signal.

NewAmsterdam Pharma Company NV (NAMS) Awesome Oscillator is -1.938, creating a Sell signal.

NewAmsterdam Pharma Company NV (NAMS) Momentum is -0.71, creating a Sell signal.

NewAmsterdam Pharma Company NV (NAMS) MACD is -0.912, creating a Sell signal.

NewAmsterdam Pharma Company NV (NAMS) Moving Average

2026-01-30

Period	Simple	Signal
MA_5	31.888	Sell
MA_10	32.557	Sell
MA_20	33.109	Sell
MA_60	35.696	Sell
MA_200	27.463	Buy
MA_250	26.055	Buy

NewAmsterdam Pharma Company NV (NAMS) 5-Day simple moving average is 31.888, while NewAmsterdam Pharma Company NV (NAMS) share price is $31.12, making it a Sell.

NewAmsterdam Pharma Company NV (NAMS) 10-Day simple moving average is 32.557, while NewAmsterdam Pharma Company NV (NAMS) share price is $31.12, making it a Sell.

NewAmsterdam Pharma Company NV (NAMS) 20-Day simple moving average is 33.109, while NewAmsterdam Pharma Company NV (NAMS) share price is $31.12, making it a Sell.

NewAmsterdam Pharma Company NV (NAMS) 60-Day simple moving average is 35.696, while NewAmsterdam Pharma Company NV (NAMS) share price is $31.12, making it a Sell.

NewAmsterdam Pharma Company NV (NAMS) 200-Day simple moving average is 27.463, while NewAmsterdam Pharma Company NV (NAMS) share price is $31.12, making it a Buy.

NewAmsterdam Pharma Company NV (NAMS) 250-Day simple moving average is 26.055, while NewAmsterdam Pharma Company NV (NAMS) share price is $31.12, making it a Buy.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for NAMS?

The overall technical consensus for NewAmsterdam Pharma Company NV (NAMS) is currently sell. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 2 buy signals and 3 sell signals.

What are the key support and resistance levels for NewAmsterdam Pharma Company NV (NAMS) today?

Based on pivot point calculations, NewAmsterdam Pharma Company NV (NAMS) has an immediate support level at 30.168 and a major resistance level at 34.948. Traders also monitor the pivot point at 32.559 to determine the intraday trend direction.

Is NewAmsterdam Pharma Company NV (NAMS) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for NewAmsterdam Pharma Company NV (NAMS) is currently 37.943. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for NewAmsterdam Pharma Company NV (NAMS)?

NewAmsterdam Pharma Company NV (NAMS) Moving Averages Convergence Divergence (MACD) indicator is -0.912, suggesting NAMS is sell. This indicator helps identify potential trend reversals or momentum shifts for NewAmsterdam Pharma Company NV.

How is NewAmsterdam Pharma Company NV (NAMS) performing relative to its 200-day moving average?

NewAmsterdam Pharma Company NV (NAMS)is currently trading at $31.12, which is above its 200-day simple moving average of 27.463. Trading above the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.